Strata Critical Medical (SRTA) Change in Accured Expenses (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Change in Accured Expenses data on file, last reported at -$2.2 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 5.27% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 759.1% YoY) and the FY2025 annual result came in at $2.4 million, up 128.52% from the prior year.
• Change in Accured Expenses retreated to -$2.2 million in Q1 2026 per SRTA's latest filing, from $795000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $5.0 million in Q4 2023 and bottomed at -$10.2 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $795000.0 (2025), against an average of $322800.0.
• The widest annual swing landed in 2023, when Change in Accured Expenses slumped 228.34%; it then surged 39850.0% in 2025.
• Tracing SRTA's Change in Accured Expenses over 5 years: stood at $1.3 million in 2022, then surged by 289.25% to $5.0 million in 2023, then slumped by 100.04% to -$2000.0 in 2024, then surged by 39850.0% to $795000.0 in 2025, then sank by 371.45% to -$2.2 million in 2026.
• Per Business Quant, the three latest SRTA Change in Accured Expenses figures stand at -$2.2 million (Q1 2026), $795000.0 (Q4 2025), and $669000.0 (Q3 2025).

Peer Comparison